Startups
Porsolt
Le Genest-Saint-Isle, Mayenne, France
Porsolt SAS is an active French preclinical contract research organization based at Le Genest-Saint-Isle near Laval, Mayenne. Its legal entity is SIREN425113321, registered November2,1999; the operating brand reports research history since1985. It supplies biopharmaceutical companies, academic institutions and nonprofits with in-vitro, ex-vivo and in-vivo drug-discovery, efficacy, pharmacokinetic, safety-pharmacology, histology and toxicology services. Its central-nervous-system research covers epilepsy, cognition and aging, neurodegeneration, psychiatric disorders, stroke, pain and dependence liability, including electrophysiology and EEG. Its glioblastoma partnership with GlioCure and CHU Angers develops patient-derived preclinical models; these are research services rather than approved medicines or demonstrated clinical efficacy. The company publicly describes GLP-compliant and AAALAC-accredited operations. Xavier Morge became President in2025, while former President and CEO Guillaume Froget became Senior Advisor. The publicly named scientific, sales and marketing team is recorded separately from external research collaborators and historical employees. Paris Apax Partners SAS, renamed Seven2 in2023, announced a majority acquisition February21,2023 with existing management and shareholders reinvesting; this is ownership, not an inferred new-cash fundraising round. Its purchase price and issuer-primary-cash allocation remain unpublished. Porsolt acquired the Bordeaux cell-assay business Fluofarma in2015. Registered share capital, sales revenue and investor AUM are not treated as fundraising. Current operating identity is verified against the official French business registry.
Team
Anne-Marie HernierPublished scientific, sales or marketing team member (January2026; individual title unpublished) |
Arezki Yanis IdresPublished scientific, sales or marketing team member (January2026; individual title unpublished) |
Arielle SimchowitzPublished scientific, sales or marketing team member (January2026; individual title unpublished) |
Carla CancioPublished scientific, sales or marketing team member (January2026; individual title unpublished) |
Christelle Froger-ColleauxPublished scientific, sales or marketing team member (January2026; individual title unpublished) |
Clarisse DuvalPublished Porsolt-affiliated research contributor (2026; employment title unpublished) |
Dalena BresslerPublished scientific, sales or marketing team member (January2026; individual title unpublished) |
David BabinPublished Porsolt-affiliated research contributor (2026; employment title unpublished) |
 David PushettDirector of Global Business Development |
Elise EsneaultPublished scientific, sales or marketing team member (January2026; individual title unpublished) |
Florian DecrouyPublished scientific, sales or marketing team member (January2026; individual title unpublished) |
Florian SimonPublished Porsolt-affiliated research contributor (2026; employment title unpublished) |
Frédéric TantotPublished Porsolt-affiliated research contributor (2026; employment title unpublished) |
Guillaume FrogetSenior Advisor (since2025); former President and CEO |
Guillaume PeyonCNS Study Director |
Jessica Bellec-DyèvrePublished scientific, sales or marketing team member (January2026; individual title unpublished) |
Laura Lockwood (Porsolt)Published scientific, sales or marketing team member (January2026; individual title unpublished) |
Marion PicardPublished Porsolt-affiliated research contributor (2026; employment title unpublished) |
Mathieu ChonéPublished Porsolt-affiliated research contributor (2026; employment title unpublished) |
Mehdi EllouzePublished scientific, sales or marketing team member (January2026; individual title unpublished) |
Mikaël PâquetPublished scientific, sales or marketing team member (January2026; individual title unpublished) |
Méliana EscodaPublished scientific, sales or marketing team member (January2026; individual title unpublished) |
Oumayma EssidPublished Porsolt-affiliated research contributor (2026; employment title unpublished) |
Philippe GuillaumeStudy Director, Safety Pharmacology |
Sabrina DjemmaliPublished scientific, sales or marketing team member (January2026; individual title unpublished) |
Solène PédronPublished scientific, sales or marketing team member (January2026; individual title unpublished) |
Sonia Goineau-BrissieuxStudy Director, Safety Pharmacology |
Sonia RompionPublished Porsolt-affiliated research contributor (2026; employment title unpublished) |
Sébastien BrécheScientific and commercial team representative (2026; individual title unpublished) |
Xavier MorgePresident (appointed2025) |